Relevium Technologies Inc. (RLLVF)
| Previous Close | 0.0008 |
| Open | 0.0008 |
| Bid | 0.0000 x 0 |
| Ask | 0.0000 x 0 |
| Day's Range | 0.0008 - 0.0008 |
| 52 Week Range | 0.0008 - 0.0516 |
| Volume | |
| Avg. Volume | 163 |
| Market Cap | 5.332M |
| Beta (5Y Monthly) | 2.62 |
| PE Ratio (TTM) | N/A |
| EPS (TTM) | -0.0280 |
| Earnings Date | N/A |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | N/A |
- GlobeNewswire
Relevium Provides Operational and Continued Disclosure Update
MONTREAL, April 21, 2022 (GLOBE NEWSWIRE) -- RELEVIUM TECHNOLOGIES INC. (TSX.V:“RLV”, OTCQB:“RLLVF” and Frankfurt: “6BX”) (the “Company” or “Relevium”), is pleased to provide an update on operations and continuous disclosure matters. UPDATE ON ONGOING OPERATIONS On December 16, 2021, the Company announced it had delivered 127.5 million medical grade nitrile gloves, representing 100% of the first of two PPE contracts that the Company had entered into for a total value of CAD$11M. On January 25 an
- GlobeNewswire
Relevium Provides Bi-Weekly Update to Management Cease Trade Order
MONTRÉAL, Jan. 05, 2022 (GLOBE NEWSWIRE) -- Relevium Technologies Inc. (the “Company” or “Relevium”) (TSXV: RLV) is providing an update to its previously disclosed management cease trade order ("MCTO"), announced on November 1, 2021, in respect of the audited annual financial statements and corresponding management's discussion and analysis for the year ended June 30, 2021, including the CEO and CFO certifications (collectively, the “Annual Financial Filings”) that were not filed by the required
